COMMUNIQUÉS West-GlobeNewswire

Crescent Biopharma Announces Grants of Inducement Awards
03/08/2026
WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
CLEVELAND, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
03/08/2026
SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic [...]
Curium Announces Definitive Agreement to Merge with Lantheus
03/08/2026
Strategic transaction would bring Curium's theranostics portfolio and global manufacturing platform together with Lantheus’ complementary U.S. radiodiagnostics business Total transaction consideration to Lantheus [...]
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
03/08/2026
Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson Experienced executive with a proven track record of [...]
Klow Peptide Stack Introduced by Kylo Peptides for Laboratory Research in 2026
03/08/2026
Each vial in the stack is released after ISO/IEC 17025 testing. A lot-matched Certificate of Analysis is published on the website. Sheridan, WY, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides today introduced the KLOW [...]
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
03/08/2026
ZUG, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses, addressing a [...]
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
03/08/2026
The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses, addressing a significant unmet medical need The FDA confirmed that [...]
Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy
03/08/2026
MELBOURNE, Australia and OXFORD, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology company developing next-generation, disease-modifying immunotherapies for food allergy, today [...]
NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer
03/08/2026
STEVENAGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company developing novel disease-modifying therapeutics that rectify mitochondrial dysfunction in [...]
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise
03/08/2026
NANJING, China, Aug. 02, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the Center for Drug Evaluation (CDE) of the National Medical [...]
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
03/08/2026
Appointments put dedicated leadership behind two separate priorities: building Ascentage Pharma’s own commercial organization in the United States, and expanding its global business development program ROCKVILLE, Md., [...]
We The Billions Launches Personalized Cognitive Care Focused on How Each Brain Works
02/08/2026
Speech-language pathologist Sanna Darwish says understanding how a brain works, not just what diagnosis it may carry, could reshape the future of cognitive care. Clarksville, MD, Aug. 01, 2026 (GLOBE NEWSWIRE) -- We The [...]
NOX Peptides Releases Updated Quality and Testing Information for Wolverine Stack Research Blend
02/08/2026
Toronto, Canada, Aug. 02, 2026 (GLOBE NEWSWIRE) -- NOX Peptides has released updated quality assurance and testing information for the Wolverine Stack research blend, providing additional transparency regarding product [...]
Appointment of new CFO
01/08/2026
ANNOUNCEMENT NO. 310 1 August 2026 Appointment of new CFO The board of ChemoMetec has appointed Phillip Massie Price as the new CFO with effect from 3 August 2026. Phillip Massie Price joins ChemoMetec from a position [...]
Precipio Announces Q2-2026 Shareholder Update Call
31/07/2026
Conference Call will be held on August 17th, 2026, at 5:00 PM EDT NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2026 [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/07/2026
VANCOUVER, BC and BOSTON, MA, July 31, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and [...]
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31/07/2026
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in combination with [...]
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
31/07/2026
TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda [...]

Pages